Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: June 2009
Alopur
02 June 2009 | New Products
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Allopurinol 100mg, 300mg. Description: White biconvex tablets. 100mg, round with single-sided score notch. 300mg, oblong with both-sided breaking notch. All tablets can be divided into equal halves. Presentation: 100mg-100,... Read more
Bellprav
02 June 2009 | New Products
Company: Ranbaxy Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Pravastatin (sodium) 10mg, 20mg, 40mg. Description: Dark yellow to yellow coloured mottled, circular, biconvex tablets. Marked with P1 on 10mg, P2 on 20mg and P3 on 40mg on one... Read more
Eucreas
02 June 2009 | New Products
Company: Novartis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Vildagliptin 50mg; metformin HCl 850mg (eq. to metformin 660mg) or 1000mg (eq. to metformin 780mg). Description: Yellow or dark yellow, ovaloid film-coated tablet with bevelled edge, imprinted with... Read more
Galvus
02 June 2009 | New Products
Company: Novartis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Vildagliptin 50mg. Description: White to light yellowish, round (8 mm diameter), flat-faced, bevelled-edge tablet. One side is debossed with NVR, and the other side with FB. Presentation: 56,... Read more
IPV-Boostrix
02 June 2009 | New Products
Company: GlaxoSmithKline (Ireland) Ltd. Legal category: Prescription. Sport permitted. Active ingredients: Diphtheria toxoid ≥ 2 IU, tetanus toxoid ≥ 20 IU, pertussis toxoid 8mcg, filamentous haemagglutinin 8mcg, pertactin 2.5mcg, inactivated poliovirus type 1, 2 and 3, adsorbed on aluminium hydroxide,... Read more
Pantium
02 June 2009 | New Products
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pantoprazole 20mg, 40mg. Description: Yellow oval gastro-resistant tablets. Presentation: 20mg-28, €12.27; 40mg-28, €22.73. Indications: Pantium 20mg: Treatment of mild reflux disease and associated symptoms (e.g. heartburn, acid regurgitation,... Read more
Pantoflux
02 June 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pantoprazole 20mg, 40mg. Description: Elliptical biconvex light yellow (20mg) or dark yellow (40mg) gastro-resistant tablets. Presentation: Prices available on request. Indications: Pantoflux 20mg: Treatment of mild reflux disease... Read more
Pantoprazole Teva
02 June 2009 | New Products
Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pantoprazole 20mg, 40mg (as sodium sesquihydrate). Description: Light brownish-yellow, oval, slightly biconvex gastro-resistant tablets. Presentation: 20mg-28, €12.27; 40mg-28, €22.72. Indications: Pantoprazole Teva 20mg: Treatment of mild reflux disease... Read more
Pantup
02 June 2009 | New Products
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pantoprazole 20mg, 40mg. Description: Yellow oval coated tablets imprinted 20 or 40 in black. Presentation: 20mg-28, €10.82; 40mg-28, €20.04. Indications: Pantup 20mg: Treatment of mild reflux disease and associated... Read more
Serlo
02 June 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Sertraline (as hydrochloride) 50mg, 100mg. Description: White, scored, biconvex, film-coated tablets. 50mg: Oval, marked with L. 100mg: Round, marked with C. Presentation: Prices available on request. Indications: Treatment... Read more
Vensir XL
02 June 2009 | New Products
Company: Morningside Healthcare Ltd. Marketed by Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine (as HCl) 75mg, 150mg. Description: Vensir XL 75mg: Peach opaque hard capsule with red radial circular bands, filled with 6 white to off-white... Read more
Zypadhera
02 June 2009 | New Products
Company: Eli Lilly & Co. (Ireland) Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Olanzapine (as palmoate monohydrate) 210mg, 300mg, and 405mg. After reconstitution, each 1ml suspension contains 150mg olanzapine. Description: Yellow solid powder and clear, colourless to slightly yellow... Read more
Strepsils Intensive now available in Honey and Lemon flavour
02 June 2009 | New this Month
Strepsils Intensive 8.75mg lozenges provide patients with a convenient, effective and well-tolerated treatment for sore throat. Strepsils Intensive provides symptomatic relief from a sore throat by coating the throat within two minutes, dissolving in under 10 minutes and providing lasting... Read more
Discontinuation of AstraZeneca products
02 June 2009 | Discontinued Products
AstraZeneca wish to notify MIMS Ireland’s readers that as part of a Global rationalisation process AstraZeneca is planning to withdraw the following products from the Irish market: • Avloclor 250 mg tablets • Paludrine 100mg tablets • Heminevrin Syrup and... Read more
Didronel 200mg tablets discontinued
02 June 2009 | Discontinued Products
Procter & Gamble Pharmaceuticals Ltd would like to inform you that as of 30th April 2009, they have withdrawn the marketing authorisation of Didronel (etidronate disodium) 200mg tablets from Ireland. As of 30th April 2009, they will not market or... Read more
Pulmoclase Paediatric Syrup discontinued
02 June 2009 | Discontinued Products
UCB (Pharma) Ireland wish to announce the cessation of marketing and supply of Pulmoclase Paediatric Syrup 100mg/5ml 250ml as of 16th April 2009. Further details may be obtained by contacting UCB (Pharma) Ireland at (01) 4637395.... Read more
Striant SR discontinued
02 June 2009 | Discontinued Products
Movianto would like to inform you that the manufacture of Striant SR tablets 30mg-60 has been discontinued. Movianto will cease distribution from 30th June 2009. If you have any questions regarding the discontinuation of Striant, please contact Movianto on (01)... Read more